Disclosed is an isolated nucleotide sequence having at least 85% sequence identity to SEQ ID NO: 1 as defined in the specification. The disclosed sequence is used in a pharmaceutical composition for treating mucopolysaccharidosis type IIIA or Sanfilippo syndrome.